Network News

European Research Council funds groundbreaking projects in paleoclimatology and cancer neuroscience The European Research Council (ERC) is awarding two valuable grants for early career researchers – two ERC Starting Grants – to Heidelberg University. One of them, worth 1.5 million euros, goes to PD Dr. Sophie Warken, who does her research at the Institutes of […]

With RACOON-LCS, PENGUIN and CanTEN, Heidelberg University’s Faculty of Medicine is leading projects on lung cancer screening, penicillin allergy and fungal infections within the Network of University Medicine (NUM), together with one other coordinating university for each project. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University are jointly leading three newly launched nationwide […]

YUMAB and ISAR Bioscience Collaborate to Develop a Novel Transferrin Receptor Antibody Platform for Delivering Therapeutics Across Blood-Brain Barrier. YUMAB GmbH (“YUMAB”), a leading antibody discovery contract research organization headquartered in Braunschweig, Germany, and ISAR Bioscience GmbH (“ISAR Bioscience”), a regenerative and translational medicine driven company based in Planegg, Germany, announced their collaboration to develop […]

Predicting whether active pharmaceutical ingredients are cardiotoxic – that is, whether they could damage the heart – is a key factor in their development. Researchers at the NMI, together with partners from academia and industry, aim to make these predictions more reliable. They are collaborating on the EU Pathfinder project HEARTCORE, which is led by […]

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

Stephanie Möllmert, independent research group leader at the Max Planck Institute for Medical Research, has been awarded a Starting Grant by the European Research Council (ERC). In the funded project REPROMECH, she plans to investigate the physical and mechanical conditions in the fallopian tube and their significance for the transport of eggs and early embryos. […]

Heidelberg, Germany, 1 September 2026 – BioMed X, a leading innovation engine for pharma, today announced the relocation of its global headquarters to LAB22 at Heidelberg Innovation Park (hip), together with the launch of a global partnership with BioLabs, a leading provider of shared laboratory infrastructure for life science innovators. Over the coming months, BioMed X will relocate its global headquarters […]

Ladenburg, Germany, 28 August 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that its wholly-owned subsidiary, Heidelberg Pharma Research GmbH, has signed a new collaboration agreement with its strategic partner Huadong Medicine Co., Ltd., Hangzhou, China. Huadong Medicine is the second-largest shareholder of Heidelberg Pharma […]